Adamis Pharmaceuticals Co... (ADMP)
NASDAQ: ADMP
· Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 7:59 PM
1.50% (1D)
| Bid | n/a |
| Market Cap | 7.25M |
| Revenue (ttm) | 12.67M |
| Net Income (ttm) | -11.56M |
| EPS (ttm) | -10.14 |
| PE Ratio (ttm) | -0.07642998027613412 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 119,482 |
| Avg. Volume (20D) | 3,113,594 |
| Open | 0.75 |
| Previous Close | 0.77 |
| Day's Range | 0.75 - 0.79 |
| 52-Week Range | 0.45 - 21.70 |
| Beta | 1.28 |
About ADMP
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the ...
Full Company Profile